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SYNOPSIS Over 90 % of the 1202 patients investigated in the 9 centres collaborating in the Inter-
national Pilot Study of Schizophrenia were traced 2 years after the initial examination and on the
average over 75 % of them were re-examined, using standardized instruments and methods. Results
indicate that patients diagnosed as schizophrenic on the basis of standardized assessments and clearly
specified diagnostic criteria demonstrated very marked variations of course and outcome over a 2-year
period. Schizophrenic patients in the centres in developing countries had considerably better course
and outcome than schizophrenic patients in the centres in developed countries.
INTRODUCTION
The International Pilot Study of Schizophrenia
(1PSS) began in 1966 as a large-scale cross-
cultural collaborative project carried out simul-
taneously in 9 countries differing considerably
in their sociocultural characteristics: China,
Colombia, Czechoslovakia, Denmark, India,
Nigeria, the Union of Soviet Socialist Republics,
the United Kingdom, and the United States
of America. The study was sponsored by WHO
and funded jointly by WHO, NIMH, and the 9
field research centres.
It set out to lay the methodological groundwork
for future epidemiological and other research in
schizophrenia and the other functional psychoses,
and to provide information about the nature of
schizophrenia.
With regard to methodology, the IPSS
aimed:
(1) to investigate the feasibility of large-scale
international studies requiring the collaboration
of psychiatrists and other mental health workers
1
 This project is sponsored by the World Health Organiza-
tion and funded by the World Health Organization, the
National Institute of Mental Health (USA) and the parti-
cipating field research centres.
* Address for correspondence: Dr A. Jablensky, Division
of Mental Health, WHO, Geneva, Switzerland.
with different cultural and theoretical back-
grounds;
(2) to develop standardized instruments and
procedures for psychiatric assessment that could
be applied reliably in a variety of cultural
settings;
(3) to train teams of research workers to use
such instruments and procedures so that com-
parable observations could be made in developed
and developing countries.
With regard to information on the nature of
schizophrenia, the study set out to explore in
what sense it could be said that schizophrenic
disorders exist in different parts of the world; to
identify symptomatological and other clinical
similarities and dissimilarities between groups of
patients who are diagnosed as suffering from
schizophrenia in different cultures as well as be-
tween groups of patients with diagnosis of
schizophrenia and with diagnosis of other func-
tional psychoses; to determine the extent to which
dissimilarities between schizophrenic patients in
different settings are the result of variations
in diagnostic practice or a reflexion of culture-
related differences in the manifestations of the
disorder; and to investigate whether the course
and outcome of schizophrenia differ from country
to country.
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Table 1. Composition of groups of units of analysis*
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Groups
Quantitative psychomotor
disorder
Qualitative psychomotor
disorder
Quantitative disorder of
form of thinking (and
speech)
Qualitative disorder of
form of thinking (and
speech)
Affect-laden thoughts
Predelusional signs
Experiences of control
Delusions
Neurasthenic complaints
Lack of insight
Distortion of self-
perception
Units of analysis
(symptoms)
1. Overactivity
2. Retardation
3. Stupor
14. Repetitive movements
4. Negativism
5. Compliance
7. Stereotypies
9. Grimacing
10. Posturing
11. Mannerisms
12. Hallucinatory
behaviour
13. Waxy flexibility
15. Flight of ideas
16. Pressure of speech
18. Mutism
19. Restricted speech
124. Distractibility
20. Neologisms
21. Klang association
22. Speech dissociation
23. Irrelevance
25. Blocking
26. Stereotypy of speech
27. Echolalia
28. Gloomy thoughts
29. Elated thoughts
30. Hopelessness
31. Suicidal thoughts
33. Delusional mood
34. Ideas of reference
35. Questioning reasons
for being
37. Perplexity
38. Thought alienation
39. Thoughts spoken aloud
40. Delusions of control
41. Persecution
42. Guilt
43. Self-depreciation
44. Nihilistic
45. Grandeur
46. Reference
47. Presence of delusional
system
48. Hypochondriacal
49. Special mission
50. Religious
51. Fantastic
52. Sexual
53. Impending doom
54. Obsessive thoughts
55. Worries
56. Lack of concentration
57. Memory difficulties
58. Hypochondriacal
59. Undecided
119. Decreased interest
60. Lack of insight
61. Changed appearance
63. Looking at self
64. Break of self-identity
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Groups
Derealization
Auditory hallucinations
'Characteristic'
hallucinations
Other hallucinations
Pseudo-hallucinations
Depressed-elated
62.
65.
66.
67.
69.
70.
68.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
32.
84.
85.
Anxiety, tension, irritability 86.
88.
89.
90.
Flatness
Incongruity
Other affective change
Indication of personality
change
Disregard for social norms
Other behavioural change
Psychophysical
91.
92.
93.
95.
94.
97.
98.
101.
102.
8.
103.
104.
105.
106.
110.
108.
109.
6.
17.
96.
100.
111.
112.
113.
114.
Units of analysis
(symptoms)
Derealization
Distortion of time
perception
Presence of verbal
hallucinations
Voices speak to patient
Non-verbal auditory
hallucinations
Presence of auditory
hallucinations
Voices speak full
sentences
Voices discussing
patient
Hallucinations from
body
Voices comment on
patients' thoughts
Voices speak thoughts
Visual
Tactile
Olfactory
Sexual
Somatic
Gustatory
Auditory
Visual
Special depression
Depressed mood
Observed elated mood
Morose mood
Irritability
Tension
Situation anxiety
Anxiety
Flatness
Apathy
Incongruity of affect
Ecstatic mood
Haughtiness
Ambivalence
Lability of affect
Ambitendence
Odd appearance and
behaviour
Change of interest
Change of sex
behaviour
Autism
Abnormal tidiness
Social withdrawal
Disregard for norms
Self-neglect
Talking to self
Disorder of pitch
Giggling to self
Demonstrative
Early waking
Worse in morning
Worse in evening
Diminished appetite
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Table 1 (cont.)
Groups
Units of analysis
(symptoms)
26. Cooperation difficulties,
circumstances-related
115. Sleep problems
116. Increased appetite
117. Increased libido
118. Decreased energy
120. Decreased libido
121. Constipation
125. Biological treatment
128. Environmental
circumstances
129. Speech impediments
Groups
Units of analysis
(symptoms)
27. Cooperation difficulties,
patient-related
36. Suspiciousness
122. Suggestibility
123. Poor rapport
126. Unwilling to cooperate
127. Inadequate description
• Five units of analysis ('perseveration', 'frequent auditory hallucinations', 'groaning', Moss of emotions', and 'increased
interest') were excluded because they did not fit well into any of the groups and it was considered inappropriate to create
5 new groups to accommodate them.
By design, the IPSS was not an epidemio-
logical study, and no attempt was made to
identify samples representative of the populations
of patients in the centres. Instead a number of
operationally defined selection crtieria was used
to screen at each field research centre all patients
contacting a psychiatric service during a one-year
period and to ensure inclusion in the project of
patients within the age range 15-44 who had
non-organic psychotic illnesses of a relatively
recent onset and who would be likely to be
available for follow-up.
The IPSS was carried out in three phases: a
preliminary phase, an initial evaluation phase,
and a follow-up phase. During the preliminary
phase administrative, operational and organiza-
tional procedures were established and tested. In
the initial evaluation phase, a total of 1202
patients was selected for study in the 9 field
research centres, and given a detailed standard-
ized clinical examination. Of these 1202 patients,
811 had received a clinical diagnosis of schizo-
phrenia, 164 a diagnosis of affective psychosis,
and 227 of other psychoses or non-psychotic
conditions. In the follow-up phase, the original
patients were traced and re-examined twice: 2
years and 5 years after the initial evaluation.
The methodology and results of the initial
evaluation phase of the IPSS have been described
in detail elsewhere (WHO, 1973, 1975) and will
only be given in outline to provide a background
to the preliminary findings of the 2-year follow-up
study.
Each patient selected for inclusion received an
initial evaluation by the field research centre staff
using a set of standardized instruments of which
the 3 basic ones were the Present State Examina-
tion (PSE), the Psychiatric History Schedule, and
the Social Description Schedule. On the average,
the evaluation of one patient took about 5 hours
and resulted in the accumulation of some 1600
items of information.
For the purposes of the study the PSE was
translated into 7 languages and interlanguage
equivalence was achieved through the reiterative
back-translation method and 'target-checks' of
meaning.
The psychiatrists from the collaborating centres
received intensive training in the use of the instru-
ment prior to the data collection phase, and the
reliability of their assessments was controlled
through simultaneous interviews repeated at
regular intervals in the course of the study. Such
exercises took place both between investigators
within individual centres and between investi-
gators from different centres. On the level of
individual PSE items, the intraclass correlation
coefficient between raters within centres was, on
the average, 0-77. When items were combined
into 'units of analysis' corresponding to symp-
toms, or into larger groupings ('groups of units
of analysis') reflecting broad areas of psycho-
pathology, such as delusions, hallucinations, etc.
(Table 1), reliability was even higher, of the order
of 0-81-0-84. Inter-centre reliability was some-
what lower - median intraclass correlation co-
efficient values being 0-45 for units of analysis
and 0-57 for groups of units, but high enough to
allow inter-centre comparison of psychopath-
ology.
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The two other principal instruments - the
Psychiatric History and the Social Description
schedules - covered systematically the past his-
tory of the patient and provided data on his social
environment, socioeconomic status, occupational
and educational record. The investigators using
these schedules received considerable prior
training. In view of the difficulties in assessing the
reliability of such instruments across cultures,
the rigorous procedure used in the case of the
PSE was replaced by simpler methods with par-
ticular emphasis on joint ratings and development
of agreed definitions.
During the 2-year and 5-year re-evaluations,
the patients were re-examined with the PSE and
with the follow-up history and social description
instruments. In addition to the ratings, narrative
histories of the patients' progress during the
follow-up phase were supplied by the centres.
The narrative histories were rated on a number
of course and outcome variables (e.g. length of
the episode of inclusion, proportion of the follow-
up period during which the patient was in
psychotic episodes, pattern of course, clinical
type of subsequent episodes, level of social
functioning, overall outcome), and this informa-
tion was used to supplement ratings made in the
schedules and evaluate course and outcome.
Data obtained with the PSE were used to
generate symptom profiles of patients which
could be compared within and between diagnostic
groups and centres.
Since one of the aims of the study was to
investigate how the diagnostic concepts of schizo-
phrenia and other functional psychoses were
applied in different settings, and whether a diag-
nosis of a functional psychotic disorder made at
one point in time predicted meaningful dimen-
sions of the'subsequent course and outcome of the
patients in different cultures, several different
methods were developed and applied to the
diagnostic classification of patients: clinical diag-
nosis, computer-simulated reference diagnosis, a
mathematical clustering technique, and a com-
bination of the above 3 methods.
Clinical diagnosis was recorded in terms of
ICD categories. The intra-centre reliability of
clinical diagnosis, measured as agreement rates
obtained in series of paired simultaneous inter-
views, proved to be very high: the agreement on
a diagnosis of schizophrenia was, on the average,
91-3%.
To standardize the diagnostic procedure and
provide a reference classification of the study
patients, the CATEGO computer program
using as input PSE data (Wing et al. 1974) was
utilized. The computer classification of patients
turned out to be in agreement with the clinical
diagnosis in a very high proportion (87 %) of the
patients.
McKeon's (1967) hierarchical clustering meth-
od provided a third classification of the patients
by grouping all 1202 patients into 10 statistical
clusters on the basis of maximum number of
common characteristics.
Finally, the patients in whom the clinical and
the computer diagnosis of schizophrenia agreed,
and who were classified into the 3 statistical
clusters which turned out to contain more schizo-
phrenic patients than could be expected on a
random basis, were designated as a 'concordant'
group of schizophrenics, and were analysed
further as distinct from patients who had received
a diagnosis of schizophrenia but were not classi-
fied as schizophrenic by the computer program,
or included in the statistical clusters containing
an excess number of schizophrenics. The 'con-
cordant' group was of particular interest, since
it included patients in whom the diagnosis of
schizophrenia was expected to be least influenced
by the individual predilections of the diagnostic-
ians and therefore might provide clues to possible
transcultural features of the disorder. Patients
belonging to the' concordant' group were identi-
fied in all the 9 centres of the study. The similarity
of symptom profiles among 'concordant' groups
from different centres was even higher than the
similarity of profiles of the groups of all schizo-
phrenics.
The main findings of the initial evaluation
phase of the IPSS can be summarized as
follows:
(1) The group of patients given a clinical diag-
nosis of schizophrenia in one centre tended to
have a symptom profile similar to that of groups
of patients given the same diagnosis in the other
centres. This was also true of patients with
psychotic depressive illnesses (ICD categories
2960, 296-2, 2980). When the profiles of groups
of schizophrenic and groups of psychotic depres-
sive patients were compared it was found that
the profiles of these 2 diagnostic groups were
markedly different from one another, both over-
all and within each of the centres in which
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numbers were large enough to make comparisons
possible.
(2) There was a high level of agreement be-
tween the CATEGO classification and clinical
diagnosis in 7 of the centres and a fair degree of
agreement in the other 2 centres (Moscow and
Washington). This finding suggests that the
psychiatrists' diagnostic rules had been approxi-
mated in a precisely specified way in the computer
program and that certain common diagnostic
principles were applied by the psychiatrists in
all centres.
Thus, the initial evaluation phase of the IPSS
demonstrated that it is possible to identify
schizophrenic patients who are similar with
regard to a number of specified clinical character-
istics in all the 9 cultures in which the field
research centres of the study are located.
In addition, the initial phase demonstrated
that it is feasible to carry out large scale colla-
borative studies in psychiatry and that teams of
research workers can be trained to use standard-
ized research instruments and procedures (includ-
ing the PSE which was shown to be an acceptable,
applicable and reliable instrument in all of the
9 centres) so that comparable observations of
psychiatric patients can be made both in devel-
oped and developing countries.
METHODOLOGY OF THE 2-YEAR
FOLLOW-UP PHASE
An attempt was made to find and re-evaluate as
many of the original 1202 patients as possible 2
years after their initial evaluation. As a result,
97-1 % of all patients were traced, and in all
centres an average of 75-6 % were seen and re-
examined using the PSE and a follow-up history
and social description schedule.1
The reliability of psychiatric assessments
during the follow-up phase was maintained by
continuing training and reliability excercises at
regular intervals. Meetings and exchanges of
visits of collaborating investigators organized
throughout the study provided an opportunity
for discussion and agreement on study plans and
1
 In 2 centres over 90 % of the patients were re-interviewed;
in 3 centres more than 80 %; in another 3 more than 70 %;
and in 1 centre because of staff shortage PSE interviews were
carried out with 21 % of the patients only, but otherwise
detailed progress notes were made available and follow-up
history and social description schedules filled in. If the centre
with a low proportion of re-examined patients is excluded,
the average percentage of re-examined patients would be 82-1.
their changes and proved to be an essential
mechanism for coordination in this collaborative
venture.
Data obtained with the PSE at follow-up were
used for comparisons of symptomatology within
and between diagnostic groups and centres, and
for comparisons with the initial evaluation pro-
files. Data obtained with the follow-up psychiatric
history and social description schedules (which
were supplemented by narrative summaries) were
used to determine for each patient the following
measures of course and outcome:
(i) length of the episode of inclusion,
(ii) proportion of the follow-up period during
which the patient was in psychotic episodes,
(iii) pattern of course (e.g. continuous, remit-
ting with or without relapses, etc.),
(iv) clinical type of subsequent episodes,
(v) degree of social impairment,
(vi) proportion of the follow-up period during
which the patient was out of hospital,
(vii) overall outcome (a combined measure
taking into account the proportion of the follow-
up period during which the patient was psychotic,
degree of social impairment, and type of remis-
sion).
These measures were used to compare the
course and outcome of patients across diagnostic
groups and centres and to assess the predictive
power of characteristics of the patients and their
illness at initial evaluation. They were also used
in analyses of the validity of the different systems
of classification that were applied in the
study.
MAIN RESULTS OF THE 2-YEAR
FOLLOW-UP
The results of the 2-year follow-up phase are
presented in detail in Volume II of the Report
of the International Pilot Study of Schizophrenia
(WHO, 1978). The following is a summary of
some of the major findings.
A. Variability of the course and outcome of
schizophrenia
Schizophrenic patients who were symptomato-
logically homogeneous on initial evaluation and
whose disorders clinically corresponded to the
strict definition of schizophrenia underlying the
CATEGO program, showed a marked variability
of 2-year course and outcome, both within the
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Length of episode of inclusion (months)
(data on 565 followed -up patients)
% patients
0 5 10 15 20 25 30 35
<1
1-3
3-9
9-18
>18
a b
1
3
% of follow-up in psychotic episodes
(data on 559 followed-up patients)
% patients
0 5 10 15 20 25 30 35
1-5
6-15
46-75
76-100
Pattern of course
(data on 570 followed-up patients)
% patients
0 5 10 15 20 25 30 35
Symptomatic state on follow-up
(data on 543 followed-up patients)
"/„ patients
0 5 10 15 20 25 30 35
Full remission after initial
episode, no relapses
Partial remission after initial
episode + no relapses
At least one subsequent episode,
full remission
At least one subsequent episode,
incomplete remission
Still in episode of inclusion
at time of follow-up
Psychotic
Symptomatic but
not psychotic
Symptom free
FIG. 1. Course and outcome measures, a = with full remission; b = without full remission.
series of patients investigated in each centre, and
in the study population as a whole.
When the range of possible outcomes was
divided into 5 overall outcome categories it was
found that some patients had a very favourable
2-year outcome. Thus, 26 % of the schizophrenics
fell into the best outcome group (i.e. were
psychotic less than 15 % of the time of the follow-
up, were not socially impaired, and had full
remission). On the other hand, however, 18 %
fell into the worst outcome group (i.e. were both
continuously psychotic and severely impaired);
while the remaining 56 % were distributed over
the 3 intermediate categories. Considering the
pattern of course, 27 % of all schizophrenics had
a single, relatively short psychotic episode fol-
lowed by full recovery without relapses and social
impairment (in about 17 % of all patients the
illness lasted less than 6 weeks). At the other
extreme, 26 % never had a full remission during
the 2-year period. At the moment of the 2-year
follow-up evaluation, one-third of the schizo-
phrenic patients were found to be symptom-free;
more than a quarter, however, were still in the
psychotic episode which occasioned their in-
clusion in the study.
Fig. 1 presents the percentage of schizophrenic
patients that fell into the various outcome groups
for 4 of the course and outcome measures (length
of episode of inclusion, percentage of time
psychotic, pattern of course, symptomatic pic-
ture at 2-year follow-up) and Fig. 2 shows the
distribution of patients over the overall outcome
categories.
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FIG. 2. Distribution of 543 followed-up schizophrenic patients
over 5 categories of 2-year overall outcome. Categories of
outcome:
1 = very favourable - includes: psychotic for less than 15 %
of the follow-up period, then full remission; no severe social
impairment.
2 = favourable - includes any of the following: (a) psychotic
for less than 15 % of the follow-up period, then remission
with some residual symptoms but no severe social impair-
ment; (6) psychotic for 16-45 % of the follow-up period, then
full remission and no severe social impairment.
3 = intermediate - includes any of the following: (a) psycho-
tic for less than 15 % of the follow-up period, then remission
with'Or without residual symptoms, but with social impair-
ment; (6) psychotic for 16-45 % of the follow-up period, then
either remission with residual symptoms but no severe social
impairment or full remission with severe social impairment;
(c) psychotic for 46-75 % of the follow-up period, then
remission (full or with residual symptoms) but no severe
social impairment.
4 = unfavourable - includes any of the following: (a) psycho-
tic for 46-75 % of the follow-up period, then full remission
but severe social impairment; (6) psychotic for over 76%
of the follow-up period, then remission (full or with residual
symptoms) but no severe social impairment.
5 = very unfavourable - includes any of the following: («)
psychotic for 46-75 % of the follow-up period, then remission
with residual symptoms and severe social impairment: (b)
psychotic for over 76 % of the follow-up period, then remis-
sion (full or with residual symptoms) and severe social
impairment.
B. Variability of course and outcome of
schizophrenia according to centre
When course and outcome of the schizophrenic
patients were analysed by centres and by groups
of centres, striking and consistent differences
emerged between patients in centres in the devel-
oping countries and patients in centres in the
developed countries.1 On virtually all course and
outcome measures, the group of schizophrenic
patients from Agra, Cali and Ibadan had on the
average better course and outcome than the
group of patients from Aarhus, London, Moscow,
1
 Taipei was not included in these analyses because it did
not fit clearly into either of the 2 groups.
40
30
20
10
Good
outcome
Patients
in developing
countries
, J I
I
r Patients in
v—I I developed
I countries
I
I
1 2 3 4 5
 P o o r
Categories of outcome outcome
FIG. 3. Distribution of 233 followed-up schizophrenic patients
in developing countries and 295 followed-up schizophrenic
patients in developed countries over 5 categories of 2-year
overall outcome. The categories of outcome are as defined
in Fig. 2.
Prague and Washington. When individual centres
were compared, schizophrenic patients in Ibadan
and Agra had the best course and outcome
among the schizophrenic patients in all centres.
Fifty-eight per cent of initial evaluation Ibadan
schizophrenics and 47 % of initial evaluation
Agra schizophrenics followed up were symptom-
free at the time of 2-year follow-up and 36 % of
Ibadan schizophrenics and 27 % of Agra schizo-
phrenics had an episode of inclusion that lasted
for less than one month followed by a full re-
mission without any relapses.
Only 5 % of the Ibadan schizophrenics fell into
the worst overall outcome group. For every out-
come variable the schizophrenic patients in
Ibadan and Agra had a significantly better out-
come than those in Aarhus, London, Washington
and Prague, with those in Cali and Moscow being
intermediate. The markedly different distribu-
tions of patients in centres in developing and
developed countries over the 5 categories of
overall outcome are shown on Fig. 3.
The differences in course and outcome among
the centres and between the group of centres in
developing countries and the group of centres in
developed countries were not due to differences
in the ratio of patients with more and less recent
onset of the disorder prior to the inclusion into
the study, since these differences did not disap-
pear or diminish substantially when the groups
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were controlled for length of illness before in-
clusion in the study. The interpretation of these
results is a complex matter and the conclusions
that can be drawn from them are discussed in
Volume II of the Report of the IPSS (WHO,
1978).
C. Course and outcome of schizophrenia com-
pared with that of other functional psychoses
Schizophrenic patients in the IPSS had the worst
course and outcome on every course and outcome
measure of any of the diagnostic groups included
in the study. For all centres combined these
differences were statistically significant and
intra-centre differences, although not always
statistically significant, were generally in the
direction of schizophrenic patients having a less
favourable course and outcome than patients in
other diagnostic groups. Differences between
schizophrenic patients and patients with affective
psychoses on course and outcome measures were
statistically significant in centres in developed
countries and not significant for any of the course
and outcome variables in centres in developing
countries. Possible explanations for this finding
are discussed in Volume II of the Report of
the IPSS (WHO, 1978).
Despite the consistent and significant differ-
ences between schizophrenic patients and patients
with psychotic depression, where individual
measures of course and outcome are considered,
these differences do not appear to be large
enough to allow clear-cut separation of patients
in the 2 groups on the basis of course and outcome
only. Discriminant function analysis indicated
that if patients were to be classified into these 2
diagnostic groups solely on the basis of type of
course and outcome, the rate of misclassification
would be quite high (about 40 %).
D. Predictors of course and outcome
Predictor variables selected from the results of
the standardized assessment of patients at initial
evaluation were divided into 3 classes - socio-
demographic variables, past history variables,
and characteristics of the episode of inclusion.
Course and outcome variables were defined in
terms of the measures described above and the
analysis of predictors was carried out using the
statistical technique of step-wise multiple regres-
sion analysis.
The major findings of these analyses can be
summarized as follows :
(1) The amount of variance for any of the
course and outcome variables that could be
accounted for by the 5 best predictors was rela-
tively low, ranging from 8 to 22 %. For the 15
best predictors taken together, it was never higher
than 27 %. This suggests that no single factor and
no combination of a small number of' key' factors
had a very strong association with the course
and outcome of schizophrenia and also that part
of the variance in the course and outcome of
schizophrenic patients in this study might be
related to factors not included among the
variables assessed.
(2) The 3 classes of predictors - sociodemo-
graphic factors, past history factors, and episode
of inclusion factors - were found to be about
equal with regard to their predictive power.
(3) Three sociodemographic predictors ap-
peared consistently among the best predictors of
this class: social isolation, associated with a poor
outcome; marital status - widowed, divorced or
separated, associated with a poor outcome; and
marital status - married, associated with a good
outcome.
(4) Three past history predictors consistently
emerged among the best predictors of this class:
history of past psychiatric treatment, poor
psychosexual adjustment, and unfavourable en-
vironment - all associated with poor outcome.
(5) Among characteristics of the episode of
inclusion, 2 factors appeared consistently among
the best predictors: duration of the length of the
episode of inclusion prior to initial evaluation
(long duration associated with poor outcome)
and insidious onset, associated with a poor out-
come. Other predictors included presence of
precipitating factors, derealization and affective
symptoms, associated with good outcome, and
flatness of affect, associated with poor out-
come.
(6) The proportion of course and outcome
variance that could be explained by the best
predictors was different for the groups of schizo-
phrenics in the developing and developed count-
ries, with the predictive power of the best predic-
tors being considerably higher in the developed
countries. Furthermore, there were differences
between patients from centres in developed and
developing countries with regard to the specific
factors which werethe best predictors of outcome.
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Table 2. Predictors of several measures of course and outcome in schizophrenic patients
(all centres)
% variance
explained by 5
Best predictors best predictors
Course and outcome variable
and number of patients in
the analysis
Length of the episode of inclusion
(565 patients)
Proportion of the follow-up period in
which patient was in psychotic
episodes (559 patients)
Full remission without relapses after
the initial episode (154 patients)
Remittent course with relapses
(172 patients)
Continuous illness, no remissions
(150 patients)
Social impairment on follow-up
(585 patients)
Length of episode prior to initial assessment 15
Social isolation
Score on derealization
Psychiatric treatment in the past
History of behaviour disturbance
Social isolation 12
Length of episode prior to initial assessment
Psychiatric treatment in the past
Sex
Type of onset
Sudden onset 14
No psychiatric treatment in the past
No personality change
Married
Short duration of episode prior to initial assessment
Female sex 7
Depression or elation
Higher occupational level
Neurotic complaints
Absence of precipitating stress
Long duration of episode prior to initial assessment 14
Social isolation
Divorced, separated or widowed
Absence of derealization
History of behaviour disturbance
Social isolation 20
Long duration of episode prior to initial assessment
Psychiatric treatment in the past
Marital status other than currently married
No physical illness or disability in the past
(7) There were considerable differences be-
tween the best predictors for schizophrenia and
the best predictors for affective psychoses.
Some of the main findings about the predictors
of 2-year course and outcome in schizophrenic
patients are summarized in Table 2.
The IPSS results provide some support for
hypotheses previously held about the relationship
between particular predictors and outcome. At
the same time they suggest that predictive factors
identified for study in European and North
American cultures may not be very suitable for
the study of prognosis in other cultures, and that
a large part of the variance in the course and
outcome of schizophrenia is related to factors
which are yet to be identified.
£. Approaches toward an assessment of diagnostic
validity
The lack of clear-cut external validating criteria
has made the assessment of the validity of diag-
nostic classification systems a difficult matter. In
the IPSS the question of diagnostic validity was
approached in 2 ways: from the point of view of
the temporal consistency of the symptomatology
of the patients classified into a defined diagnostic
group, and from the point of view of the extent to
which the classification of patients into a parti-
cular diagnostic category predicts the course and
outcome of their disorders.
Symptom profiles of groups of patients given
the diagnosis of schizophrenia at initial evalua-
tion who were psychotic at the time of follow-up
showed a significant similarity to the same pa-
tients' initial evaluation profiles. The percentage
of initial evaluation schizophrenic patients con-
sidered to be psychotic at follow-up that fell into
the same CATEGO class on both initial evalua-
tion and follow-up was high, ranging from 72 %
in Washington to 100 % in London.
If schizophrenic patients had subsequent
psychotic episodes these were predominantly of
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the schizophrenic type. However, 17 % had sub-
sequent affective episodes (Sheldrick et al. 1977).
On the whole, these results seem to support the
concept of the temporal consistency of schizo-
phrenic symptomatology.
Symptomatological criteria and diagnostic
categories, however, turned out to be far less
effective predictors of 2-year course and outcome
defined by dimensions such as length of initial
illness episode, proportion of the follow-up
during which the patient was in psychotic epi-
sodes, pattern of course (e.g. remitting, with or
without relapses, recurrent or continuous),
degree of social impairment, or a combination
of several of the above measures. Results of the
multivariate analyses indicate that although there
were significant differences there was also con-
siderable overlap in the type of course and out-
come of patients placed in different diagnostic
groups.
The separation of the patients with a clinical
diagnosis of schizophrenia from patients with
a diagnosis of psychotic depression in terms of
course and outcome was not as good as the sep-
aration of schizophrenic and manic patients
(Mahalanobis' mean distance coefficients for the
pairs of distributions in discriminant function
analysis 0-58 and 1-36 respectively).
The discrimination between schizophrenia and
psychotic depression on the basis of course and
outcome was better when only concordant
schizophrenics were included in the analyses and
also when the analyses were carried out in terms
of CATEGO S (representing schizophrenia) and
CATEGO D (representing psychotic depression)
classes instead of in terms of field research centre
diagnoses.
Concerning the predictive validity of the dis-
tinctions between subtypes of schizophrenia, of
the various groupings attempted (in order to
obtain sufficient number of cases for analysis)
only the distinction between the combined group
of simple and hebephrenic schizophrenics, on
one hand, and the group of schizoaffective patients
on the other hand, achieved a reasonable level of
separation in terms of course and outcome
(Mahalanobis' distance 1-06).
In general, it was found that the clinical,
CATEGO, and ' concordant' - ' non-concord-
ant ' classification systems were better predictors of
the future type of symptomatology than they were
of course and outcome variables such as length of
episode of inclusion, percentage of time psychotic,
social functioning and pattern of course.
DISCUSSION AND CONCLUSIONS
More than 70 years ago, Kraepelin (1904) sug-
gested that 'comparative psychiatry' defined as
'the observation of mental disorders in different
groups of people' could substantially advance
our knowledge about the causes and nature of
mental disorders but warned that ' reliable com-
parison is, of course, only possible if we are able
to draw clear distinctions between identifiable
illnesses, as well as between clinical states; more-
over, our clinical concepts vary so widely that for
the foreseeable future such comparison is possible
only if the observations are made by one and the
same observer'.
The International Pilot Study of Schizophrenia
was an effort to overcome some of the difficulties
which in the past undermined the validity of many
attempts to compare observations on psychiatric
patients made by different researchers in different
settings, and impeded the development of a
common language for describing the phenomena
of major mental disorders. The results of the first
2 phases of the IPSS and the methodological
experience gained since the first patient was
examined in this study in 1968 demonstrated the
feasibility of assessing and following up in a
standardized and comparable way psychiatric
patients in different cultures by research workers
from those cultures, provided that:
(i) they undergo extensive training in the use of
standardized research instruments and proce-
dures ;
(ii) an organizational framework is set up to
ensure both frequent contacts between the col-
laborating investigators and central coordination
of work;
(iii) research methods and instruments are
developed which are applicable and acceptable
in different cultural settings, and can be utilized
reliably within and across the different settings.
Further to demonstrating that international
comparisons of psychopathology and prospective
observations on psychiatric patients are feasible,
the IPSS generated a wealth of cross-cultural data
which gave rise to a large number of hypotheses
about the nature of schizophrenia and the effects
that the social and cultural environment may
have on its course and outcome.
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In considering the findings of the IPSS caution
must be used against unwarranted generalizations
since by design the study did not attempt to select
representative samples of all schizophrenic
patients or of all patients with other functional
psychoses in the different settings where the re-
search centres were located.
The findings of the 2-year follow-up which
come foremost to attention are:
(i) the very marked variability of course and
outcome of patients diagnosed as schizophrenic
according to strict symptomatological criteria,
(ii) the consistent differences of course and out-
come between groups of schizophrenic patients
in different cultural settings, in the sense that
patients in centres in developing countries had
considerably more favourable course and out-
come than patients in centres in developed
countries.
The observed variability of course and out-
come can support both the view that many
schizophrenic patients do surprisingly well in
their subsequent lives, and the argument stressing
the fact that in a significant proportion of the
patients the disorder has a very poor prognosis
and leads to severe impairments and disability.
The emphasis on the one or the other aspect will
depend on the issue in question, but in any case
the findings so far indicate that a clinical diagnosis
of schizophrenia alone (even if based on strictly
defined criteria), does not provide sufficient
ground for a firm statement about the patient's
likely pattern of course, probability of relapses
and remissions, and degree of social impairment
in the future.
This conclusion does not intend to call in
question the validity of the conventional system
of psychiatric classification, but rather to point
out some of its limitations and warn against
unrealistic expectations of a classification's
predictive capacity, especially when diagnostic
categorization is applied to individuals in very
different social and cultural settings. At present
it is impossible to say whether the relatively low
predictive power of diagnosis is due to its over-
inclusiveness or whether sociocultural factors
have such a powerful impact on the course and
outcome that no prediction can be. made even if
our diagnostic skills were to reach a very high
level.
This is particularly so in the case of the indi-
vidual patient. However, the demonstration that
35
as a group schizophrenic patients had a more
severe course and outcome than the other groups
of psychotic patients, all assessed according to
the same standardized data collection procedures
and the same outcome criteria, indicates that
classification into groups of disorders according
to symptomatology does have significant prog-
nostic implications. Moreover, temporal consis-
tency of symptomatology, as a measure of
validity of a diagnostic classificationtwas shown
to be high, indicating that, at least over a short
period, clinical diagnosis is a good predictor of
future symptomatology. The fact that there was
a greater difference between the course and out-
come and subsequent symptomatology of patients
classified in CATEGO classes S and D than
between the course and outcome of patients with
a field research centre diagnosis of schizophrenia
and psychotic depression suggests that the more
strictly diagnostic categories are defined, the
greater their predictive validity.
The overlap between the short-term course and
outcome of schizophrenia on the one hand and
of affective psychoses, on the other, shows that
the belief that schizophrenia usually has a poor
outcome and affective psychoses a good outcome
may be wrong. The degree of overlap suggests
caution in predictions of differences in length of
episodes, proportion of time psychotic, level of
social functioning, and pattern of course, based on
clinical diagnosis alone. Many of the course and
outcome variables may be influenced by factors
other than the characteristics that are usually
considered in defining the categories of a clinical
diagnostic classification, and a number of such
factors were identified in the analysis of predictors
of course and outcome. Some of the predictors -
e.g. social isolation or marital status - point
clearly to the importance of psychosocial influ-
ences on the course and outcome of schizo-
phrenic disorders, while others, like type of onset,
presence or absence of precipitating factors,
psychosexual adjustment, etc., suggest that a
more careful enquiry about such characteristics
in a conventional clinical assessment can yield
rewards in terms of better prognostic evaluation.
The finding that factors usually studied as
possible predictors of outcome do not account
for a very high proportion of the total variance in
the course and outcome of schizophrenia suggests
that it is important to look for other potential
predictors of outcome. In particular it suggests
PS M 7
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that predictors identified in European and North
American cultures are not necessarily relevant to
other cultures.
The finding that schizophrenic patients in the
centres in developing countries (particularly in
Ibadan and Agra) had a better course and out-
come on all variables than the schizophrenics in
the centres in the developed countries is perhaps
the most important outcome of the 2-year follow-
up study. If confirmed by 5-year follow-up results
it would have significant implications for both
service organization and for directions of future
research. Several hypotheses have already been
formulated to explain these differences and future
work will focus on investigations to test them.
It is possible, of course, that the symptomato-
logically similar groups of schizophrenic patients
in the different centres included varying propor-
tions of patients suffering from functional psycho-
tic conditions, which, although presenting with
schizophrenic symptoms, could be otherwise
different from schizophrenia. Consideration of
this possibility raises important theoretical ques-
tions about psychiatric nosology and also calls
for investigation as to whether there are, on
initial examination, symptoms that would allow
distinguishing the 'disease' schizophrenia from
prognostically benign 'schizophreniform' states.
Type of onset, precipitating factors and other
possible such variables were already mentioned
in the discussion of predictors of course and out-
come and will be the object of further study.
Also, evidence obtained so far supports the
thesis that there is a relationship between variables
linked to culture and the social environment, and
the prognosis of schizophrenia. The size of the
family group and the nature of interaction be-
tween its members, the existence or absence of
crystallized social stereotypes of the 'schizo-
phrenic', the extent of availability of specialized
medical and social welfare services which might
reinforce such stereotypes, etc., are examples of
such factors which will need to be studied further.
A 5-year follow-up of IPSS patients has been
carried out and data analysis for this phase of
the study is under way. These analyses will make
it possible to determine whether the differences
in course and outcome in different cultures and
different diagnostic groups become greater, less,
or remain the same over a longer period of time.
In addition, a new study, aiming to replicate the
findings on cross-cultural differences in the prog-
nosis of schizophrenia, and to test some of the
hypotheses about possible influences of culture-
related factors mentioned above, is being under-
taken.
SUMMARY
Over 90 % of the 1202 patients investigated in the 9
countries collaborating in the IPSS were traced 2
years after the initial examination and, on the average,
over 75 % of them were re-examined, using stan-
dardized instruments and methods. Results of this
phase indicate that patients diagnosed as schizo-
phrenic on the basis of standardized assessments and
clearly specified diagnostic criteria demonstrated very
marked variations of course and outcome over a
2-year period. Schizophrenic patients in the centres
in developing countries had on the average consider-
ably better course and outcome than schizophrenic
patients in the centres in developed countries. Part
of the variation of course and outcome was related
to sociodemographic (e.g. social isolation, marital
status) and clinical (e.g. type of onset, precipitating
factors) predictors but another larger part remained
statistically unexplained. This suggests that variables
usually used to describe psychopathology, the envir-
onment and history of psychiatric patients in Euro-
pean and North American cultures may not be
sufficient to account for cross-cultural differences.
Hypotheses concerning the relationship between
culture and schizophrenia have been formulated and
initial approaches made towards assessing the validity
of systems of classification of psychiatric disorders.
Diagnostic classification of patients on initial evalua-
tion appeared to be consistently associated with
patterns of symptomatology observed during the
follow-up, but less so with the length of the episodes,
the total time during which the patient was psychotic,
pattern of course, or the degree of social impairment.
A 5-year follow-up of the IPSS patients has also been
completed and the collected data are being analysed.
The collaborating investigators in this study have
been Dr N. Sartorius, principal investigator, Dr T.-Y.
Lin, former principal investigator, and Ms E. M.
Brooke, Dr F. Engelsmann, Dr G. Ginsburg, Mr W.
Gulbinat, Dr A. Jablensky, Mr M. Kimura, Dr A.
Richman, and Dr R. Shapiro at the Headquarters of
the World Health Organization in Geneva, Switzer-
land; Dr E. Stromgren, chief collaborating investi-
gator, and Drs A. Bertelsen, M. Fischer, C. Flack
and N. Juel-Nielsen at the field research centre in
Aarhus, Denmark; Dr. K. C. Dube, chief collabor-
ating investigator, and Dr B. S. Yadav at the field
research centre in Agra, India; Dr C. Leon, chief
collaborating investigator, and Drs G. Calderon and
E. Zambrano at the field research centre in Cali,
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Colombia; Dr T. A. Lambo, chief collaborating in-
vestigator, and Dr T. Asuni and Dr M. O. Olatawura
at the field research centre in lbadan, Nigeria; Dr
J. K. Wing, chief collaborating investigator, and
Drs J. Birley and J. P. Leffat the field research centre
in London, United Kingdom; Dr R. A. Nadzharov,
chief collaborating investigator, and Dr N. M.
Zharikov at the field research centre in Moscow,
USSR; Dr. L. Hanzlicek, chief collaborating investi-
gator, and Dr C. Skoda at the field research centre
in Prague, Czechoslovakia; Dr C. C. Chen and Dr
M. T. Tsuang, at the field research centre in Taipei,
China; and Drs L. Wynne and J. Strauss, chief col-
laborating investigators, and Drs J. Bartko and W.
Carpenter at the field research centre in Washington,
D.C., USA.
A list of other staff contributing to the IPSS can
be found in the Report of the International Pilot
Study of Schizophrenia, Volume I, World Health
Organization (1973).
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